eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2019
vol. 15
 
Share:
Share:
more
 
 
abstract:
Clinical research

An evaluation of the usefulness of extracorporeal liver support techniques in patients with severe liver dysfunction

Mariusz Piechota, Anna Piechota, Małgorzata Misztal, Szymon Bernas, Iwona Pietraszek-Grzywaczewska

Arch Med Sci 2019; 15, 1: 99–112
Online publish date: 2017/05/25
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The mortality rate in patients with severe liver dysfunction with no option of transplantation is unacceptably high. The main aim of this study was to evaluate the usefulness of applying extracorporeal liver support (ECLS) techniques in this group of patients.

Material and methods
Data from hospital admissions of 101 patients with severe liver dysfunction who were admitted to the department of Anaesthesiology and intensive therapy between 2006 and 2015 were retrospectively analysed. The study group was divided into two subgroups. Standard Medical therapy (SMT) was a subgroup of patients receiving standard Medical therapy, and SMT + ECLS was a subgroup containing patients receiving standard medical therapy complemented by at least one extracorporeal liver support procedure.

Results
Significantly lower intensive care unit (ICU) mortality and 30-day mortality rates were found in the SMT + ECLS subgroup (p = 0.0138 and p = 0.0238 respectively). No difference in 3-month mortality was identified between the two groups. In a multivariate model, independent risk factors for ICU mortality proved to be the SOFA score and prothrombin time. The highest discriminatory power for ICU mortality was demonstrated for the SOFA score, followed by APACHE II, SAPS II, MELD UNOS and GCS scores. For 30-day mortality, however, the best discriminatory power was shown for the SAPS II score, followed by SOFA, APACHE II, MELD UNOS and GCS scores.

Conclusions
Further studies are needed to assess the contribution of non-biological extracorporeal liver support procedures to a decrease in mortality rates in the population of patients with severe liver dysfunction.

keywords:

fractionated plasma separation and adsorption, single pass albumin dialysis, sequential organ failure assessment

references:
EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012; 57: 399-420.
Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012; 56 Suppl. 1: 39-45.
Oshea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010; 105: 14-32.
Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003; 38: 24-31.
Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005; 43: 142-8.
Catalina MV, Barrio J, Anaya F, et al. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 2003; 23 Suppl. 3: 39-43.
Laleman W, Wilmer A, Evenepoel P, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.
Parés A, Cisneros L, Salmerón JM, et al. The molecular adsorbent recirculating system (MARS) improves systemic hemodynamics and hepatic encephalopathy in patients with severe alcoholic hepatitis. J Hepatol 2002; 36 Suppl. 1: 150.
Parés A, Deulofeu R, Cisneros L, et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009; 13: R8.
Hassanein T, Tamsen MR, Petcharaporn L, Hassanemin R, Monson P, Baralak F. Extracorporeal albumin dialysis improves survival in patients with severe alcoholic hepatitis. Hepatology 2012; 56: 974A.
Bañares R, Nevens F, Larsen FS, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153-62.
Kribben A, Gerken G, Haag S, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 782-9.e3.
Heemann U, Treichel U, Loock J, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36: 949-58.
El Banayosy A, Kizner L, Schueler V, Bergmeier S, Cobaugh D, Koerfer R. First use of the molecular adsorbent recirculating system technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004; 50: 332-7.
Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transplant 2004; 10: 1109-19.
Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-51.
Demetriou AA, Brown Jr RS, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-70.
Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013; 159: 522-31.
Hassanein TI, Tofteng F, Brown Jr RS, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46: 1853-62.
Dethloff T, Tofteng F, Frederiksen HJ, Hojskov M, Hansen BA, Larsen FS. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled trial study. World J Gastroenterol 2008; 14: 2065-71.
Piechota M, Piechota A. An evaluation of the usefulness of extracorporeal liver support techniques in patients hospitalized in the ICU for severe liver dysfunction secondary to alcoholic liver disease. Hepat Mon 2016; 16: e34127.
Falkenhagen D, Strobl W, Vogt G, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999; 23: 81-6.
Rifai K, Ernst T, Kretschmer U, et al. Prometheus® – a new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39: 984-90.
Evenepoel P, Laleman W, Wilmer A, et al. Detoxifying capacity and kinetics of Prometheus® – a new extracorporeal system for the treatment of liver failure. Blood Purification 2005; 23: 349-58.
Khuroo MS, Khuroo MS, Farahat KLC. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transplant 2004; 10: 1099-106.
Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the Molecular Adsorbent Recirculating System. Therap Apheresis 2001; 5: 417-22.
Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transplant 2003; 9: 290-297.
Chen S, Zhang L, Shi Y, Yang X, Wang M. Molecular adsorbent recirculating system: clinical experience in patients with liver failure based on hepatitis B in China. Liver 2002; 22 Suppl. 2: 48-51.
Hessel FP, Mitzner SR, Rief J, Guellstorff B, Steiner S, Wasem J. Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver International 2003; 23 Suppl. 3: 66-72.
Camus C, Lavoué S, Gacouin A, et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006; 32: 1817-25.
Wittebole X, Hantson P. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clin Toxicol 2011; 49: 782-93.
Zhou XM, Miao JY, Yang Y, et al. Clinical experience with molecular adsorbent recirculating system (MARS) in patients with drug-induced liver failure. Artif Organs 2004; 28: 483-6.
He GL, Feng L, Duan CY, et al. Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure. Int J Clin Exp Med 2015; 8: 17046-54.
Krisper P, Haditsch B, Stauber R, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451-7.
Stadlbauer V, Krisper P, Beuers U, et al. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J 2007; 53: 187-93.
Rademacher S, Oppert M, Jörres A. Artificial extracorporeal liver support therapy in patients with severe liver failure. Exp Rev Gastroenterol Hepatol 2011; 5: 591-9.
Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Gibney RT. Acetaminophen-induced acute liver failure treated with single-pass albumin dialysis: report of a case. Intern J Artif Organs 2008; 31: 450-5.
Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 2008; 23: 1013-6.
Piechota M. Hepatic encephalopathy in the course of alcoholic liver disease – treatment options in the intensive care unit. Anaesthesiol Intensive Ther 2014; 46: 34-6.
Piechota M, Piechota A. An evaluation of the usefulness of single pass albumin dialysis: key role of dialysate flow rate. Crit Care 2016; 20: 156.
Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study. Crit Care 2016; 20: 2.
O’Shea RS, Dasarathy S, McCullough AJ, et al. Alcoholic liver disease. Hepatology 2010; 51: 307-28.
Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg 2011; 98: 623-31.
Jalan R, Gines P, Olson JC, et al. Acute-on chronic liver failure. J Hepatol 2012; 57: 1336-48.
Arroyo V, Moreau R, Jalan R, Ginès P. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol 2015; 62 Suppl. 1: S131-43.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe